Clicky

Anika Therapeutics Inc.(ANIK)

Description: Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.


Keywords: Medicine Laser Stem Cell Acid Bone Therapeutic Products Osteoarthritis Dermatology Wound Ulcer Ophthalmic Burns Cataracts Dysfunction Hyaluronic Acid Scar Healing Wound Care Products Bone Marrow Knee Mesenchymal Stem Cell Oral And Maxillofacial Surgery Glycosaminoglycans Intraocular Lens Bone Grafting Treatment Of Osteoarthritis Wrinkle Therapeutic Joint Dysfunction

Home Page: www.anikatherapeutics.com

ANIK Technical Analysis

32 Wiggins Avenue
Bedford, MA 01730
United States
Phone: 781 457 9000


Officers

Name Title
Dr. Cheryl Renee Blanchard Ph.D. Pres, CEO & Director
Mr. Michael L. Levitz Exec. VP, CFO & Treasurer
Mr. David Colleran Exec. VP, Gen. Counsel & Corp. Sec.
Ms. Anne Nunes VP of Operations
Mr. Mark Namaroff Exec. Director of Investor Relations & Corp. Communications
Mr. Charles Sherwood III VP & Corp. Legal Counsel
Mr. James Chase Sr. VP of International Sales & Marketing
Mr. Bart Bracy VP of Sales & Marketing of Americas
Mr. Ben Joseph VP of Commercial & Corp. Devel.
Ms. Lisa Funiciello VP of HR

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 78.7402
Trailing PE: 0
Price-to-Book MRQ: 1.571
Price-to-Sales TTM: 2.8101
IPO Date: 1993-04-29
Fiscal Year End: December
Full Time Employees: 297
Back to stocks